We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Matthew Mossanen

Matthew Mossanen MD

Assistant Professor of Surgery, Harvard Medical School, Brigham and Women's Hospital, Division of Urology, Boston, MA

Recent Contributions to PracticeUpdate:

  1. Outcomes and Recurrence Patterns of Sarcomatoid Urothelial Carcinoma
  2. Practical Issues With Use of Edrafitinib in Urothelial Carcinoma
  3. Analysis of Recurrence After Neoadjuvant Bladder Cancer Treatment: Practical Implications
  4. ASCO: Outcomes of Patients With Metastatic Urothelial Carcinoma Following Discontinuation of Enfortumab-Vedotin
  5. ASCO: Adjuvant Chemotherapy Plus Novel Therapies for Muscle-Invasive Bladder Cancer
  6. Pattern of Adverse Events With New Immuno-Oncology Agents: Implications for Monitoring
  7. AACR: Combination Checkpoint Inhibitor and Chemotherapy for Advanced Urothelial Carcinoma
  8. Practical Approaches to BCG Unresponsive Bladder Cancer
  9. Integrating Immuno-Oncology and Targeted Therapy for Bladder Cancer in Practice
  10. Smoking Cessation and Bladder Cancer

Most Read This Week

Recently Updated